BioTech Nation ... with Dr. Moira Gunn

Episodes

Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

March 31, 2026

Space is for everyone! Dr. Daniel Kraft discusses the medical hurdles of zero-g, from short flights to Mars missions, and the tech making it possible.

Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"

March 24, 2026

Dr. Marschall Runge discusses the US healthcare crisis, misinformation, Big Tech's role, and policy changes needed for a healthier future.

Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma

March 17, 2026

NervGen Pharma's new drug challenges medical dogma, showing nerve regeneration and functional recovery is possible years after spinal cord injury.

A New Approach to Treating ALS...Dr. Arun Swaminathan, CEO, Coya Therapeutics

March 10, 2026

Coya Therapeutics aims to halt ALS progression, not cure it, using a dual-action drug to rebalance the immune system and reduce neuroinflammation.

The Future of Early Cancer Screening...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

March 3, 2026

The future of cancer care is early detection. Liquid biopsies, full-body MRIs, and AI are shifting diagnostics from late-stage to proactive screening.

ChatGPT...for Healthcare? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

February 17, 2026

OpenAI's ChatGPT Health is here, offering secure, personalized health insights by integrating your data to shift care from reactive to proactive.

AI-Powered Biology? Dr. Shana Kelley, President of Bioengineering & Head of Biohub, Chicago

February 10, 2026

Dr. Shana Kelley explains how the Chan Zuckerberg Initiative uses AI-powered biology to cure, prevent, and manage all diseases this century.

You’ve Had Back Pain for 7-10 Years? Neil Klompas, CEO, Augurex

January 27, 2026

A new blood test promises to diagnose a hidden cause of chronic back pain, axial spondyloarthritis, ending a 7-10 year diagnostic delay.

A Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma

January 20, 2026

Connect Biopharma is developing a fast-acting biologic for acute asthma & COPD flare-ups, aiming to work in hours, unlike slower drugs like Dupixent.

A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma

January 11, 2026

Tris Pharma is developing a novel opioid targeting MOP/NOP receptors to provide pain relief without the addictive euphoria, tackling the crisis.

A Speedy Intervention for Heart Attacks, Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics

January 11, 2026

A simple IV of glucose, insulin, & potassium given immediately to suspected heart attack patients can cut mortality by 50% and damage by 80%.

Can Cancer Cells be Turned Against Themselves?

January 6, 2026

EARLI engineers cancer cells to produce their own medicine using synthetic DNA, turning solid tumors into therapeutic factories.

Decoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology

December 31, 2025

Gordian Biotechnology is revolutionizing drug discovery by testing hundreds of gene therapies at once in complex, relevant animal models.

When Your Immune System Overreacts...Prof. Dr. Niels Riedemann, Co-Founder & CEO, InflaRx

December 23, 2025

InflaRx is developing a C5a inhibitor to treat the immune system's harmful overreactions in critical conditions like COVID-19, ARDS, and rare diseases.

Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo

December 17, 2025

An ALS drug failed trials, but its original inventor reacquired it, re-analyzed the data, proved its efficacy, and now seeks FDA approval.